A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors

Clinical trial NCT03312842 · COMPLETED

Trial details

NCT number: NCT03312842
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2017-10-19
Primary completion: 2021-08-16
Enrollment: 259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.